Dr. Yoshio Inoue, MD

  • Mount Vernon, WA
  • Medical oncologist
NPI1891748331PAC ID1456358712
Medicare services, 2024
12,231
Medicare patients, 2024
459
Part D claims, 2024
1,243
Publications
3
Clinical trials
1
Practice address
1415 Kincaid Street, Mount Vernon, WA 98274
Practice phone
Call (360) 424-4111
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Skagit Valley Hospital

Hospital · Mount Vernon, Washington

See all 8 affiliations

Find Dr. Inoue's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Yoshio Inoue is a medical oncologist in Mount Vernon, Washington

Dr. Inoue practices at Skagit Valley Hospital in Mount Vernon, Washington, part of Skagit Regional Health.

Dr. Inoue's NPI, 1891748331, was assigned on May 18, 2006. Dr. Inoue graduated from University of Maryland School of Medicine in 2003. Dr. Inoue holds Washington license MD00046000.

NPI and contact details
Medicare PAC ID
1456358712
NPI enumeration date
May 18, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(360) 424-4111
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
49
Medical school graduation
2003

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Yoshio Inoue practices at Skagit Valley Hospital in Mount Vernon, Washington

Dr. Inoue's primary practice is Skagit Valley Hospital, at 1415 Kincaid Street, Mount Vernon, WA 98274 in Skagit County. The practice phone is (360) 424-4111.

Source: Dmand AI Affiliation Data

Dr. Yoshio Inoue is affiliated with 6 sites of care and 2 medical groups

Dr. Inoue's primary practice is Skagit Valley Hospital in Mount Vernon, Washington, part of Skagit Regional Health. Dr. Inoue is also affiliated with Island Health. The medical group on file is The Everett Clinic. Dmand AI also links Dr. Inoue to 1 more hospital, 2 group practices and clinics, 1 community health center and 1 medical group, each named with a free account.

See all 8 affiliations for Dr. Inoue

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Yoshio Inoue's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Inoue practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Skagit Valley HospitalAvailable with a free account
+5 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Inoue practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Skagit Regional Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Yoshio Inoue is one of 145 medical oncologists in Washington

Medical oncology is Dr. Inoue's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Inoue's licenses on file in 2 states: Washington and Hawaii.

Specialties and state licenses

  • Medical oncology, WashingtonPrimaryLicense MD00046000 · taxonomy 207RX0202X
  • Internal medicine, HawaiiLicense MD13720 · taxonomy 207R00000X

Medical oncologists near Dr. Inoue

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Yoshio Inoue billed Medicare for 12,231 services in 2024

CMS data shows 12,231 Medicare services from Dr. Inoue across 31 procedure codes in 2024, for 459 Medicare patients. Medicare paid $336,940 for them.

Medicare services, 202412,231
Medicare patients459
Paid by Medicare$336,940
Procedure codes31

Dr. Inoue's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 30,8302024: 5,97281%
Other services
2023: 6,2752024: 3,90038%
Lab and pathology
2023: 1,7602024: 1,04441%
Office and hospital visits
2023: 6252024: 6595%
Surgery
2023: 6372024: 39638%
Tests and treatments
2023: 9392024: 26072%
Imaging
2023: 1122024: 0100%

Where Dr. Inoue's Medicare services took place, 2024

  • In an office11,97998%
  • In a facility2522%

Dr. Inoue compared with the Washington median for medical oncologists, 2024

  • Dr. Inoue
  • Washington median
Medicare services
12,231vs 36233.8 times
Medicare patients
459vs 1393.3 times
Part D claims
913vs 1805.1 times

Medians across 131 medical oncologists in Washington with Dmand AI profiles that report each measure.

Dr. Inoue's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Inoue

Need commercial claims for Dr. Inoue?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Inoue and other medical oncologists in Washington.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Yoshio Inoue treated 459 Medicare patients in 2024, average age 75

CMS counts 459 Medicare patients who saw Dr. Inoue in 2024. The largest group is 65 to 74, with 213 patients. 74% of them have high blood pressure, and 66% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Inoue's median patient age at 74, with 56% women.

Medicare patients, 2024459
Average age75
Average risk score2.00
Also on Medicaid8%

Dr. Inoue's Medicare patients by age, 2024

Dr. Inoue's Medicare patients by sex, 2024

  • Women22449%
  • Men23551%

Chronic conditions among Dr. Inoue's Medicare patients, 2024

  1. High blood pressure74%
  2. High cholesterol66%
  3. Cancer47%
  4. Arthritis33%
  5. Diabetes33%
  6. Chronic kidney disease31%
  7. Ischemic heart disease26%
  8. Atrial fibrillation25%

Share of Medicare patients with each condition. A patient can have several.

Dr. Inoue's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women56%
  • Men43%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Yoshio Inoue wrote 1,243 Medicare Part D claims in 2024

In 2024, Dr. Inoue wrote 1,243 Medicare Part D claims for 246 patients. 73% of them were for generic drugs. CMS names the drug for 913 of them, across 33 drugs with 11 or more claims each, at $3,714,398 in total drug cost. In 2023, CMS named 1,118 claims across 42 drugs.

Part D claims, 20241,243
Drugs named by CMS33
Total drug cost$3.7M
Part D patients246

Dr. Inoue's Part D claims by kind of drug, 2024

  • Generic911 claims73%
  • Brand-name and other332 claims27%

Dr. Inoue's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Inoue's Part D claims, 2024

  • Opioids12%144 of 1,243 claims
  • Antibiotics1%13 of 1,243 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,1182024: 91318%

Drugs named by CMS: 33 in 2024, 42 in 2023.

See all prescribing by Dr. Inoue

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Yoshio Inoue offers telehealth to Medicare patients

Dr. Inoue accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Inoue as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Dr. Inoue by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Yoshio Inoue has 3 publications on record

Dmand AI links 3 papers to Dr. Inoue, published from 2012 to 2015. Dr. Inoue's most frequent co-authors are Andrew John Cowan, MD, Michael Brian Lilly, MD and Stephen Plymate, MD.

Papers3
Years published2012 to 2015

Dr. Inoue's papers by year, 2012 to 2015

Dr. Inoue's most frequent co-authors

Recent publications by Dr. Inoue

See all 3 publications and co-authors

See who Dr. Inoue researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Inoue works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Yoshio Inoue has worked on 1 clinical trial

Dmand AI links Dr. Inoue to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Male and Breast Neoplasms.

Conditions in Dr. Inoue's trials

  • Breast Neoplasms, Male
  • Breast Neoplasms

Investigators on the most trials with Dr. Inoue

Recent clinical trials with Dr. Inoue

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Yoshio Inoue received $7,177 in industry payments from 2018 to 2025

CMS Open Payments shows 15 general payments to Dr. Inoue from 10 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Seagen Inc. paid the most, $5,692.

General payments to Dr. Inoue by program year, 2018 to 2025

General payments to Dr. Inoue by kind, 2018 to 2025

$7.2Kin total
  • Speaker and faculty fees$4,82567%
  • Consulting fees$1,00014%
  • Travel and lodging$78011%
  • Food and beverage$5608%
  • Education$120%

Companies that paid Dr. Inoue the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Inoue

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Yoshio Inoue graduated from University of Maryland School of Medicine

Dr. Inoue graduated from University of Maryland School of Medicine in 2003.

  1. Medical schoolUniversity of Maryland School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Yoshio Inoue's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Yoshio Inoue

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Yoshio Inoue's NPI number?

Dr. Yoshio Inoue's NPI number is 1891748331. It was assigned on May 18, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Yoshio Inoue?

Dr. Yoshio Inoue is a medical oncologist in Mount Vernon, Washington. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Yoshio Inoue practice?

Dr. Inoue practices at 1415 Kincaid Street, Mount Vernon, WA 98274. Dr. Inoue's primary practice is Skagit Valley Hospital in Mount Vernon, Washington, part of Skagit Regional Health. Dmand AI also links Dr. Inoue to 1 hospital, 2 group practices and clinics, 1 community health center and 1 medical group.

What is Dr. Yoshio Inoue's office phone number?

The practice phone on file for Dr. Inoue is (360) 424-4111.

What is Dr. Yoshio Inoue's medical license number?

Dr. Inoue holds Washington license MD00046000, one of the licenses on file in 2 states.

Which states has Dr. Yoshio Inoue been licensed in?

Dmand AI has state licenses on file for Dr. Inoue in Washington and Hawaii.

Which hospitals is Dr. Yoshio Inoue affiliated with?

Dr. Inoue practices at Skagit Valley Hospital in Mount Vernon, Washington. Dr. Inoue is also affiliated with Island Health. Dmand AI links Dr. Inoue to 1 more hospital.

What medical group is Dr. Yoshio Inoue part of?

Dr. Inoue is linked to The Everett Clinic. Dmand AI links Dr. Inoue to 1 more medical group.

Does Dr. Yoshio Inoue accept Medicare?

Yes. CMS data shows Dr. Inoue billed Medicare for 12,231 services in 2024, and Dr. Inoue accepts Medicare assignment.

Does Dr. Yoshio Inoue offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Inoue as offering telehealth services.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Yoshio Inoue see?

CMS counts 459 Medicare patients who saw Dr. Inoue in 2024, with an average age of 75.

What services does Dr. Yoshio Inoue bill to Medicare?

In 2024, Dr. Inoue's most billed Medicare services were injected or infused drug (J9271), medicare temporary code (Q9967) and office visit, established patient (99215).

Where did Dr. Yoshio Inoue go to medical school?

Dr. Inoue graduated from University of Maryland School of Medicine in 2003.

What drugs does Dr. Yoshio Inoue prescribe most?

In 2024 Medicare Part D data, Dr. Inoue's most prescribed drugs by claims were Oxycodone HCl, Prochlorperazine Maleate and Xtandi.

Has Dr. Yoshio Inoue received payments from drug or device companies?

CMS Open Payments shows $7,177 in general payments to Dr. Inoue from 10 companies from 2018 to 2025. The largest total came from Seagen Inc.

How long has Dr. Yoshio Inoue been practicing?

Dr. Inoue graduated from medical school in 2003, 23 years ago.

Does Dr. Yoshio Inoue do research?

Dmand AI links 3 publications to Dr. Inoue, published from 2012 to 2015. Dr. Inoue has worked on 1 clinical trial.

Who does Dr. Yoshio Inoue publish with?

Dr. Inoue's most frequent co-authors are Andrew John Cowan, MD (1 shared paper), Michael Brian Lilly, MD (1 shared paper) and Stephen Plymate, MD (1 shared paper).

Selling to medical oncology practices?

See medical oncologists in Washington by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)